Prognostic evaluation of preoperative combined treatment for advanced cancer in the lower rectum with radiation, intraluminal hyperthermia, and 5-fluorouracil suppository

Am J Surg. 1996 Mar;171(3):346-50. doi: 10.1016/S0002-9610(97)89639-0.

Abstract

Background: Since 1977, we have studied preoperative treatments using 5-fluorouracil (5-FU) suppositories alone or in combination with radiation to reduce local recurrence and improve survival of patients with rectal cancer.

Patients and methods: We developed a novel preoperative therapy combining radiation, intraluminal hyperthermia, and 5-FU suppositories. Thirty-five patients with rectal cancer underwent surgery after this treatment, and 41 patients underwent surgery without pretreatment.

Results: The patients who underwent preoperative combination treatment showed significant tumor reduction; 2 achieved microscopically complete regression. In comparison with the patients who underwent surgery without pretreatment, the preoperative treatment group had a 16.7% lower local recurrence rate (10.4% versus 27.1%) and an improved survival rate (81.8% versus 67.6%).

Conclusions: Preoperative combination therapy is a promising modality for the patients with respectable advanced cancer in the lower rectum.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Combined Modality Therapy
  • Female
  • Fluorouracil / administration & dosage*
  • Follow-Up Studies
  • Humans
  • Hyperthermia, Induced*
  • Male
  • Middle Aged
  • Preoperative Care
  • Prognosis
  • Rectal Neoplasms / mortality
  • Rectal Neoplasms / radiotherapy
  • Rectal Neoplasms / therapy*
  • Remission Induction
  • Suppositories
  • Survival Rate

Substances

  • Antimetabolites, Antineoplastic
  • Suppositories
  • Fluorouracil